Dietary supplement GMPs proposed rule should await further discussion, CRN urges.
This article was originally published in The Tan Sheet
Executive Summary
DIETARY SUPPLEMENT GMPs ADDITIONAL DISCUSSION NEEDED BEFORE RULE STAGE, the Council for Responsible Nutrition recommends in June 6 comments to FDA. "The continuing emergence of important questions strongly suggests to CRN that there is a need for additional discussion before this process goes to the next step of a proposed rule," the comments state. FDA published the advance notice of proposed rulemaking on dietary supplement Good Manufacturing Practice regs in February ("The Tan Sheet" Feb. 10, pp. 2-5).
You may also be interested in...
Herbal/Botanical Ingredient Identity Multiple Testing Recommended By FAC
Herbal and botanical products should undergo multiple tests to confirm the identity of their dietary ingredients, the FDA Food Advisory Committee Working Group on Ingredient Identity Testing, Records and Retention says in a draft report. FAC voted at a June 25 meeting in Arlington, Va. to submit the draft, along with all minority reports and a record of comments made at the meeting, to FDA's Center for Food Safety & Applied Nutrition.
Herbal/Botanical Ingredient Identity Multiple Testing Recommended By FAC
Herbal and botanical products should undergo multiple tests to confirm the identity of their dietary ingredients, the FDA Food Advisory Committee Working Group on Ingredient Identity Testing, Records and Retention says in a draft report. FAC voted at a June 25 meeting in Arlington, Va. to submit the draft, along with all minority reports and a record of comments made at the meeting, to FDA's Center for Food Safety & Applied Nutrition.
Herbal/Botanical Ingredient Identity Multiple Testing Recommended By FAC
Herbal and botanical products should undergo multiple tests to confirm the identity of their dietary ingredients, the FDA Food Advisory Committee Working Group on Ingredient Identity Testing, Records and Retention says in a draft report. FAC voted at a June 25 meeting in Arlington, Va. to submit the draft, along with all minority reports and a record of comments made at the meeting, to FDA's Center for Food Safety & Applied Nutrition.